Romeo R. Dizon - 16 Sep 2026 Form 4 Insider Report for IRIDEX CORP (IRIX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 Sep 2026, 16:26:39 UTC
Prior SEC filing
14 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon

Key filing fact

Romeo R. Dizon filed Form 4 for IRIDEX CORP (IRIX) on 16 Sep 2026.

Key facts

  • This page summarizes Romeo R. Dizon's Form 4 filing for IRIDEX CORP (IRIX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Sep 2026, 16:26.

Change

  • Previous filing in this sequence was filed on 14 Sep 2026.
  • Current net transaction value: +$4,977.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001658282 Primary reporting owner

Dizon Romeo R

Relationship
Chief Financial Officer
Address
1212 TERRA BELLA AVENUE, MOUNTAIN VIEW
Signature
/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon
Signature date
16 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRIX transaction

Common Stock

Purchase

Transaction value
$4,977
Shares
+7,900
Change %
+4.5%
Price
$0.6300
Shares after
185,306
Date
16 Sep 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .